Brief: Destiny Pharma Announces Start Of New XF-73 Research Programme

Destiny Pharma

05/07/2022 07:24

July 5 (Reuters) - Destiny Pharma PLC  DEST.L :
    * DESTINY PHARMA PLC - DESTINY PHARMA ANNOUNCES START OF A
NEW
XF-73 RESEARCH PROGRAMME
    * DESTINY PHARMA PLC - AIM TO TEST XF-73 AS A POTENTIAL
PREVENTIVE
MEDICINE FOR ORAL MUCOSITIS

Source text for Eikon:  ID:nRSE2583Ra 
Further company coverage:  DEST.L 

 ((Reuters.Briefs@thomsonreuters.com;))